Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 20/74 ]
NASDAQ | Common Stock
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH.
PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
Oct 30, 24 | -0.40 Increased by +21.57% | -0.49 Increased by +18.37% |
Aug 1, 24 | -0.50 Increased by +10.71% | -0.52 Increased by +3.85% |
May 1, 24 | -0.51 Increased by +19.05% | -0.56 Increased by +8.93% |
Feb 27, 24 | -0.54 Increased by +3.57% | -0.44 Decreased by -22.73% |
Nov 8, 23 | -0.51 Increased by 0.00% | -0.51 |
Jul 27, 23 | -0.56 Decreased by -30.23% | -0.57 Increased by +1.75% |
Apr 27, 23 | -0.63 Decreased by -61.54% | -0.58 Decreased by -8.62% |
Feb 28, 23 | -0.56 Decreased by -33.33% | -0.54 Decreased by -3.70% |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Sep 30, 24 | 58.37 M Increased by +66.29% | -20.97 M Increased by +14.82% | Decreased by -35.93% Increased by +48.77% |
Jun 30, 24 | 53.35 M Increased by +61.17% | -25.63 M Decreased by -1.35% | Decreased by -48.03% Increased by +37.12% |
Mar 31, 24 | 44.54 M Increased by +82.51% | -25.96 M Increased by +6.31% | Decreased by -58.28% Increased by +48.66% |
Dec 31, 23 | 43.58 M Increased by +83.29% | -27.50 M Increased by +12.14% | Decreased by -63.11% Increased by +52.06% |
Sep 30, 23 | 35.10 M Increased by +72.50% | -24.62 M Decreased by -6.49% | Decreased by -70.14% Increased by +38.27% |
Jun 30, 23 | 33.10 M Increased by +98.33% | -25.29 M Decreased by -23.38% | Decreased by -76.38% Increased by +37.79% |
Mar 31, 23 | 24.40 M Increased by +71.90% | -27.70 M Decreased by -48.42% | Decreased by -113.53% Increased by +13.65% |
Dec 31, 22 | 23.78 M Increased by +134.53% | -31.30 M Decreased by -70.61% | Decreased by -131.66% Increased by +27.25% |